Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1435 of 5804
-
Promising drug trial for kids with rare Muscle-Weakening disease
Disease control OngoingThe primary purpose of this study is to characterize the pharmacokinetics and pharmacodynamics of treatment with ravulizumab intravenous infusion in pediatric participants with gMG.
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Sound waves may stop stubborn seizures in ICU patients
Symptom relief Recruiting nowIn this study, the investigators propose Pulsed Low-Intensity Focused Ultrasound (PLIFU) stimulation of brain regions that modulate (thalamus) or generate focal motor seizures (primary motor cortex), with the goal of ameliorating seizure activity in subjects in non-convulsive or …
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Tailored support for seniors may speed recovery after CAR-T cancer treatment
Symptom relief Recruiting nowThis clinical trial compares the effectiveness of geriatric assessment (GA) guided interventions to accelerate functional recovery after chimeric antigen receptor T-cell (CAR-T) therapy compared to standard of care (SOC) in patients 60 years and older with B-cell non-Hodgkin lymp…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Weight loss classes added to cardiac rehab may ease AFib symptoms
Symptom relief OngoingOne-in-four Canadians will be diagnosed with an abnormal heart rhythm called atrial fibrillation (AF) in their lifetime. This is expected to double by 2050, owing to an aging population and increased age- and health behaviour-associated AF risk factors (e.g., poor cardiorespirato…
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
FLASH radiotherapy: a Blink-and-You'll-Miss-It cancer treatment?
Disease control OngoingThis is a single center randomized selected Phase II study of FLASH radiotherapy (RT) versus standard of care (SOC) radiotherapy in patients with localized Cutaneous Squamous Cell Carcinoma (cSCC) or Basal Cell Carcinoma (BCC). In summary, the aims of the study are to describe a…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a heart pill beat long COVID fatigue? new trial aims to find out.
Symptom relief OngoingThe goal of this clinical trial is to evaluate the therapeutic value of an approved drug (Vericiguat) in patients with post-COVID-19 syndrome, who suffer from profound tiredness or fatigue, regardless of bed rest.The main questions it aims to answer are: • Does Vericiguat relieve…
Phase: PHASE2 • Sponsor: Charite University, Berlin, Germany • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
VA launches major trial of THC and CBD for Veterans' nerve pain
Symptom relief Recruiting nowChronic neuropathic pain (CNP) is disabling. Research on frontline treatments for CNP, shows inconsistent outcomes and dissatisfaction among Veterans. Veterans and clinicians have shown significant interest in cannabis derivatives (THC, CBD) for neuropathic pain control, but ther…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New hope for advanced skin cancer: targeted pill tested in china
Disease control CompletedThis is a Phase IV, single arm, multicenter study designed to evaluate the efficacy and safety profile of Sonidegib in chinese participants with locally advanced basal cell carcinoma (laBCC) who are not amenable to radiation therapy, curative surgery or other local therapies.
Phase: PHASE4 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New eye injection aims to halt vision loss in dry AMD
Disease control Recruiting nowThe Phase 1 safety study of VOY-101 comprises of escalating dose Cohorts, followed by a Phase 2a.
Phase: PHASE1, PHASE2 • Sponsor: Perceive Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Engineered immune cells take on Hard-to-Treat lung cancer
Disease control Recruiting nowThis is a phase 1, single-center, open-label study that enrolls adult subjects with extensive stage lung cancer or stage IV non-small cell lung cancer that is platinum-refractory and received PD-1 and/or PD-L1 therapy. The purpose of this study is to test the safety of using a ne…
Phase: EARLY_PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New combo treatment shows promise for kids with rare bone marrow failure
Disease control CompletedThe aim of this study was to investigate the safety, tolerability, and effectiveness of eltrombopag in combination with immunosuppressive therapy (IST) in real world practice in pediatric patients with severe aplastic anemia (sAA) in Korea. The study used data over a 6-month peri…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could a daily powder cut wheezing attacks in toddlers?
Disease control OngoingThis study will assess the efficacy and safety of daily OM-85 treatment compared to placebo in children aged 6 months to 5 years with recurrent wheezing
Phase: PHASE2 • Sponsor: OM Pharma SA • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Radiation after targeted therapy may keep skin cancer away
Disease control Recruiting nowLocally advanced basal cell carcinoma (BCC) are large BCCs or BCCs located in areas subject to functional and aesthetic risk following surgery or radiotherapy. In these particular situations, surgery and radiotherapy are sometimes not appropriate, and Sonic Hedgehog inhibitors (S…
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Kenya pharmacy PrEP trial: a new way to fight HIV?
Prevention CompletedA cluster-randomized control trial (cRCT) testing different cost-sharing models for the delivery of HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) services at private pharmacies in Kenya. The goal is to assess the effect of different pharmacy-based PrEP/P…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New pill for scarred lungs shows promise in early trial
Disease control CompletedThe goal of this clinical trial is to learn about INS018\_055 in adults with Idiopathic Pulmonary Fibrosis (IPF). The primary objective is to evaluate the safety and tolerability of INS018\_055 orally administered for up to 12 weeks in adult subjects with IPF compared to placebo…
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Real-world data shows REBYOTA™ may stop c. diff from coming back
Prevention CompletedThis is a prospective observational cohort study designed to collect data on patients who received REBYOTA™ for the prevention of rCDI in the routine care setting. As all data collected for this study are observational, the decision to prescribe REBYOTA™ is at the treating physic…
Sponsor: Ferring Pharmaceuticals • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
New procedure aims to stop debilitating headaches from spinal fluid leaks
Disease control Recruiting nowThe purpose of this research is to determine the efficacy of paraspinal vein embolization for treatment of digital subtraction myelography (DSM) or CT myelography (CTM) confirmed cerebrospinal fluid (CSF)-venous fistulas so that researchers can inform the development and design o…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New disc implant aims to ease pain after herniated disc surgery
Disease control TerminatedThis study is a First in Human, prospective, multi-center clinical study intended to collect safety and performance information for the Spinal Stabilization Technologies PerQdisc® Nucleus Replacement System and procedure concurrently following a successful discectomy using a mini…
Phase: NA • Sponsor: Spinal Stabilization Technologies • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden prostate cancer
Diagnosis CompletedPhase 2 randomized controlled multi-center study of IS-002, in conjunction with near-infrared (NIR) fluorescence imaging, for identification of prostate cancer during robotic-assisted radical prostatectomy (RARP) with (extended) pelvic lymph node dissection ((e)PLND) using the da…
Phase: PHASE2 • Sponsor: Intuitive Surgical • Aim: Diagnosis
Last updated Jun 26, 2026 13:38 UTC
-
Can a Phone-Based program help people with chronic pain cut back on opioids?
Disease control OngoingThis project aims to test simultaneously the effectiveness of telemedicine and collaborative management (TCM) vs. TCM plus Cooperative Pain Education and Self-Management (COPES) on patient level outcomes and the impact of site-tailored Implementation Facilitation to work toward l…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC